Acutus Medical Inc (AFIB)

$0.06 -0.03 (-33.89%)
Market Cap 2.68M
Revenue (ttm) 7.16M
Net Income (ttm) -81.66M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 1,869,100
Avg Vol 801,830
Day's Range N/A - N/A
Shares Out 29.72M
Stochastic %K 7%
Beta 0.25
Analysts Strong Buy
Price Target $1.50

Company Profile

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is h...

Industry: Medical Devices
Sector: Healthcare
Phone: 442 232 6080
Fax: 442 232 6081
Address:
2210 Faraday Avenue, Suite 100, Carlsbad, United States
MrMaxxxx
MrMaxxxx Dec. 11 at 6:00 PM
$AFIB The transfer agent for Acutus Medical (AFIB) is Computershare Trust Company, N.A. ​Here is the general contact information for Computershare for shareholder inquiries: Contact Method Phone Number / Information U.S. & Canada Toll-Free 1-877-373-6374 (This is a common general shareholder line for U.S. listed companies) Non-U.S. Shareholder Inquiries +1 (781) 575-3336 (Also seen as (781) 575-2725 for automated service) General Website www.computershare.com/investor Mailing Address Check the Computershare website for the specific P.O. Box used for overnight mail vs. standard mail for the quickest service. Call and they will tell you that the company wont allow them to release info. I have asked my attorney to write a letter And under the freedom of information act They must release it. I am just getting started with these 🤡🤡🤡
0 · Reply
MrMaxxxx
MrMaxxxx Dec. 11 at 5:54 PM
$AFIB Is it legal for a publicly traded company to withhold their transfer Agent information!? Generally, publicly traded companies are required to disclose their transfer agent information. ​In the United States, regulations from the Securities and Exchange Commission (SEC) and various exchange listing requirements mandate transparency for information essential to shareholders. ​Here's why a publicly traded company typically cannot withhold this information: ​Shareholder Relations: The transfer agent is the entity responsible for maintaining the official record of a company's shareholders, issuing and cancelling certificates, and handling lost certificates, among other things. As a shareholder, you have a right to know the contact information for the agent handling your stock records. ​Regulatory Filings: Companies often disclose their transfer agent in their annual reports (like the Form 10-K in the U.S.) and proxy materials sent to shareholders. It is called the best practice!!!
0 · Reply
MrMaxxxx
MrMaxxxx Dec. 10 at 2:30 PM
$AFIB Hired an attorney to look into the company financials when they release them. This shenanigan with stock price will not serve the insiders well. $14 million cash reported on their last 10-k And the sale of one of their holdings , not to Mention the payments due from medtronic, Does not equate to current market cap!! I am paitient and will give them another 3-4 months to come clean. I will take legal action. I hope that it doesnt come to that, But I have done so succesfully in the past! Tick Tock.
0 · Reply
MrMaxxxx
MrMaxxxx Nov. 27 at 12:19 AM
$AFIB Maeket Cap is less than $3000.00 😁😆😆😅🤣🤣😂
1 · Reply
Pawsvesting
Pawsvesting Nov. 14 at 5:07 PM
$AFIB 7 + 6 = 13
1 · Reply
Pawsvesting
Pawsvesting Nov. 14 at 5:06 PM
$AFIB No changes in ownership have been reported since then, including following the July 1, 2025, asset acquisition of Acutus Medical’s AcQMap electrophysiology platform by EnChannel Medical (an asset sale rather than a full company merger, so shares remain outstanding). As a major shareholder, Deerfield would indeed receive compensation through the asset sale proceeds distributed to equity holders, alongside other shareholders.
0 · Reply
Pawsvesting
Pawsvesting Nov. 14 at 5:05 PM
$AFIB 1,974,638 shares held by Deerfield Partners, L.P. (via Deerfield Mgmt, L.P.), equivalent to 4.90%.
0 · Reply
Pawsvesting
Pawsvesting Nov. 14 at 5:04 PM
$AFIB 3,438,589 shares held by Deerfield Private Design Fund III, L.P. (via Deerfield Mgmt III, L.P.), equivalent to 5.42%.
0 · Reply
Pawsvesting
Pawsvesting Nov. 14 at 4:51 PM
$AFIB Deerfield Management Company, L.P. (commonly referred to as Deerfield Mgmt) beneficially owns 5,492,725 shares of Acutus Medical, Inc. common stock, representing approximately 9.10% of the company’s outstanding shares as of the latest available SEC filing on January 28, 2025.
0 · Reply
Pawsvesting
Pawsvesting Oct. 30 at 1:31 AM
$AFIB “In their 2022 and 2023 disclosures, Acutus Medical confirms this deadline and that the second closing remains uncompleted. “
0 · Reply
Latest News on AFIB
No data available.
MrMaxxxx
MrMaxxxx Dec. 11 at 6:00 PM
$AFIB The transfer agent for Acutus Medical (AFIB) is Computershare Trust Company, N.A. ​Here is the general contact information for Computershare for shareholder inquiries: Contact Method Phone Number / Information U.S. & Canada Toll-Free 1-877-373-6374 (This is a common general shareholder line for U.S. listed companies) Non-U.S. Shareholder Inquiries +1 (781) 575-3336 (Also seen as (781) 575-2725 for automated service) General Website www.computershare.com/investor Mailing Address Check the Computershare website for the specific P.O. Box used for overnight mail vs. standard mail for the quickest service. Call and they will tell you that the company wont allow them to release info. I have asked my attorney to write a letter And under the freedom of information act They must release it. I am just getting started with these 🤡🤡🤡
0 · Reply
MrMaxxxx
MrMaxxxx Dec. 11 at 5:54 PM
$AFIB Is it legal for a publicly traded company to withhold their transfer Agent information!? Generally, publicly traded companies are required to disclose their transfer agent information. ​In the United States, regulations from the Securities and Exchange Commission (SEC) and various exchange listing requirements mandate transparency for information essential to shareholders. ​Here's why a publicly traded company typically cannot withhold this information: ​Shareholder Relations: The transfer agent is the entity responsible for maintaining the official record of a company's shareholders, issuing and cancelling certificates, and handling lost certificates, among other things. As a shareholder, you have a right to know the contact information for the agent handling your stock records. ​Regulatory Filings: Companies often disclose their transfer agent in their annual reports (like the Form 10-K in the U.S.) and proxy materials sent to shareholders. It is called the best practice!!!
0 · Reply
MrMaxxxx
MrMaxxxx Dec. 10 at 2:30 PM
$AFIB Hired an attorney to look into the company financials when they release them. This shenanigan with stock price will not serve the insiders well. $14 million cash reported on their last 10-k And the sale of one of their holdings , not to Mention the payments due from medtronic, Does not equate to current market cap!! I am paitient and will give them another 3-4 months to come clean. I will take legal action. I hope that it doesnt come to that, But I have done so succesfully in the past! Tick Tock.
0 · Reply
MrMaxxxx
MrMaxxxx Nov. 27 at 12:19 AM
$AFIB Maeket Cap is less than $3000.00 😁😆😆😅🤣🤣😂
1 · Reply
Pawsvesting
Pawsvesting Nov. 14 at 5:07 PM
$AFIB 7 + 6 = 13
1 · Reply
Pawsvesting
Pawsvesting Nov. 14 at 5:06 PM
$AFIB No changes in ownership have been reported since then, including following the July 1, 2025, asset acquisition of Acutus Medical’s AcQMap electrophysiology platform by EnChannel Medical (an asset sale rather than a full company merger, so shares remain outstanding). As a major shareholder, Deerfield would indeed receive compensation through the asset sale proceeds distributed to equity holders, alongside other shareholders.
0 · Reply
Pawsvesting
Pawsvesting Nov. 14 at 5:05 PM
$AFIB 1,974,638 shares held by Deerfield Partners, L.P. (via Deerfield Mgmt, L.P.), equivalent to 4.90%.
0 · Reply
Pawsvesting
Pawsvesting Nov. 14 at 5:04 PM
$AFIB 3,438,589 shares held by Deerfield Private Design Fund III, L.P. (via Deerfield Mgmt III, L.P.), equivalent to 5.42%.
0 · Reply
Pawsvesting
Pawsvesting Nov. 14 at 4:51 PM
$AFIB Deerfield Management Company, L.P. (commonly referred to as Deerfield Mgmt) beneficially owns 5,492,725 shares of Acutus Medical, Inc. common stock, representing approximately 9.10% of the company’s outstanding shares as of the latest available SEC filing on January 28, 2025.
0 · Reply
Pawsvesting
Pawsvesting Oct. 30 at 1:31 AM
$AFIB “In their 2022 and 2023 disclosures, Acutus Medical confirms this deadline and that the second closing remains uncompleted. “
0 · Reply
Pawsvesting
Pawsvesting Oct. 30 at 1:30 AM
$AFIB “The acquisition by Medtronic plc of certain assets from Acutus Medical, Inc. (specifically their left-heart access portfolio) had a first closing on June 30, 2022. Under the agreement, a second closing was to occur at a date determined by Medtronic but no later than the fourth anniversary of the first closing (i.e., no later than June 30, 2026) subject to customary conditions. “
1 · Reply
Pawsvesting
Pawsvesting Oct. 30 at 1:28 AM
$AFIB After a month of calling the Carlsbad, CA office to no avail, I am convinced we are waiting for the second closing. Either Martha is getting fired and nothing will happen, or the dumb FED JPowell lowering interest rates pushed woke Medtronic to restart acquisitions. Lets see. Medtronic’s dirty hands are all over this as usual.
1 · Reply
MrMaxxxx
MrMaxxxx Oct. 17 at 2:03 PM
$AFIB Can officers of a company be personally sued by share holders? We might have to do just that. Yes, officers of a company can be personally sued by shareholders, though the circumstances in which this occurs are typically limited and fall into two main categories: direct lawsuits and derivative lawsuits. 6 months gentelman before you are served! 😄😁😆😆😅🤣🤣😂🤣🤣😅😅🤣😂😂 It's coming.
0 · Reply
MrMaxxxx
MrMaxxxx Oct. 17 at 1:45 PM
$AFIB Our steamed management team is Withholding the information regarding the Transfer agent from OTC MARKET SITE!! I guess to not be transparent, But the management team is responsible To shareholders and they will come clean One way or in the court. If they dont file 10K, then its time to send A subpoena letter. I guess some times one has to ENFORCE THE LAW!! My favorate task. 😁
1 · Reply
MrMaxxxx
MrMaxxxx Oct. 10 at 1:49 PM
$AFIB Market cap under $12000.00 now! It will cost them more than that to file Banktrupcy! 😁😆😆😅😅🤣😂😂😂😂🤣😅😅😅
0 · Reply
MrMaxxxx
MrMaxxxx Oct. 9 at 7:09 PM
$AFIB Up 100% on the day, Yet market cap Is is than $30,000.00 😁😆😆😅😅🤣😂😂😂🤣🤣😅😅😆😅 One would think that the office futniture Is worth more!!! Only in America. 😁😆😅😅🤣🤣😂😂😂
0 · Reply
MrMaxxxx
MrMaxxxx Oct. 8 at 5:42 PM
$AFIB Deerfield owns shit ton of stocks and Obviously not selling. Volume tells you that. I will stay thirsty in the swamp.
1 · Reply
Pawsvesting
Pawsvesting Sep. 26 at 6:38 PM
$AFIB no trades since 9/19 as per Fidelity.
1 · Reply
MrMaxxxx
MrMaxxxx Sep. 14 at 1:22 PM
$AFIB Based on available data, the ownership breakdown for AFIB stock (Acutus Medical, Inc.) is as follows: ​Insiders: Approximately 19.61% of the stock is owned by insiders. This includes individuals and entities with a significant stake in the company, such as corporate officers, board members, and 10% shareholders. ​Institutions: Institutional ownership is reported to be very low, at approximately 0.00706%.
0 · Reply
MrMaxxxx
MrMaxxxx Sep. 14 at 1:12 PM
$AFIB In summery, Given their contract with Medtronic is up to January 2027 And the company has annunced that they are Fully founded till then, And the fact that IMHO the company is buying Back their own shares QUIETLY! I see no reason to panic! Worse case, A CLASS ACTION WILL BE IN ORDER TO GET THEM TO COME CLEAN! We still have time for that. ME LIKES😁
0 · Reply
MrMaxxxx
MrMaxxxx Sep. 14 at 1:06 PM
$AFIB ​Cost of the System: While not the sale price of the company, the cost to a hospital or clinic for a new 3D cardiac mapping system can provide a benchmark. A typical 3D cardiac mapping system can cost anywhere from $150,000 to $500,000, excluding the cost of the single-use catheters used for each procedure. ​Conclusion ​While the market for electrophysiology mapping systems is in the billions of dollars and a single system can cost hundreds of thousands, it's impossible to determine the exact sale price of the AcQMap platform without a public announcement from the companies involved. The valuation is a result of a negotiation based on the technology's strategic value, the competitive landscape, and the financial circumstances of the companies involved!!!! Hmmmm..........
0 · Reply
MrMaxxxx
MrMaxxxx Sep. 14 at 1:04 PM
$AFIB Factors that Influence Valuation ​The "customary valuation" for an electrophysiology mapping system like the AcQMap is not a single price but a range influenced by several factors, including: ​Market Size: The overall cardiac mapping and electrophysiology market is large and growing. Recent reports indicate the global cardiac mapping market was valued at around $2.62 billion in 2025 and is projected to reach over $6.5 billion by 2034. The potential of a product to capture a share of this market is a key driver of its value. ​System Capabilities and Technology: The AcQMap system is a high-resolution, non-contact mapping system, which distinguishes it from some conventional systems. Its unique technology and clinical data on its effectiveness (such as the RECOVER AF study results) would be a primary valuation driver.
0 · Reply